Karine Flem-Karlsen

8PUBLICATIONS
58CO-AUTHORS
Molecular targetsTumour immunologyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 07, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

|Dec 21, 2025
Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade.

Ronan Talty, Veronica T Brooks, Meaghan K McGeary

|Aug 19, 2025
Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity.

Karine Flem-Karlsen, Ronan Talty, Meaghan K McGeary

|Jul 17, 2023
IL-7R licenses a population of epigenetically poised memory CD8+ T cells with superior antitumor efficacy that are critical for melanoma memory.

Goran Micevic, Andrew Daniels, Karine Flem-Karlsen

|Mar 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Rahmad Akbar, Habib Bashour, Puneet Rawat

|Jan 10, 2020
Soluble AXL as a marker of disease progression and survival in melanoma.

Karine Flem-Karlsen, Marta Nyakas, Inger Nina Farstad

Pageof 2

Frequent Collaborators

3 joint publications

Goran Micevic

2 joint publications

Koonam Park

2 joint publications

Simon F Roy

2 joint publications

Veronica T Brooks